CHAPTER 1. INTRODUCTION
1.1. RESEARCH OBJECTIVE
1.2. SCOPE OF THE STUDY
1.3. DEFINITION
CHAPTER 2. RESEARCH METHODOLOGY (PREMIUM INSIGHTS)
2.1. RESEARCH APPROACH
2.2. DATA SOURCES
2.3. ASSUMPTIONS & LIMITATIONS
CHAPTER 3. EXECUTIVE SUMMARY
3.1. MARKET SNAPSHOT
CHAPTER 4. MARKET VARIABLES AND SCOPE
4.1. INTRODUCTION
4.2. MARKET CLASSIFICATION AND SCOPE
4.3. INDUSTRY VALUE CHAIN ANALYSIS
4.3.1. RAW MATERIAL PROCUREMENT ANALYSIS
4.3.2. SALES AND DISTRIBUTION CHANNEL ANALYSIS
4.3.3. DOWNSTREAM BUYER ANALYSIS
CHAPTER 5. COVID 19 IMPACT ON ULTRASOUND MARKET
5.1. COVID-19 LANDSCAPE: ULTRASOUND INDUSTRY IMPACT
5.2. COVID 19 - IMPACT ASSESSMENT FOR THE INDUSTRY
5.3. COVID 19 IMPACT: GLOBAL MAJOR GOVERNMENT POLICY
5.4. MARKET TRENDS AND OPPORTUNITIES IN THE COVID-19 LANDSCAPE
CHAPTER 6. MARKET DYNAMICS ANALYSIS AND TRENDS
6.1. MARKET DYNAMICS
6.1.1. MARKET DRIVERS
6.1.2. MARKET RESTRAINTS
6.1.3. MARKET OPPORTUNITIES
6.2. PORTER’S FIVE FORCES ANALYSIS
6.2.1. BARGAINING POWER OF SUPPLIERS
6.2.2. BARGAINING POWER OF BUYERS
6.2.3. THREAT OF SUBSTITUTE
6.2.4. THREAT OF NEW ENTRANTS
6.2.5. DEGREE OF COMPETITION
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1.1. COMPANY MARKET SHARE/POSITIONING ANALYSIS
7.1.2. KEY STRATEGIES ADOPTED BY PLAYERS
7.1.3. VENDOR LANDSCAPE
7.1.3.1. LIST OF SUPPLIERS
7.1.3.2. LIST OF BUYERS
CHAPTER 8. GLOBAL ULTRASOUND MARKET, BY PRODUCT
8.1. ULTRASOUND MARKET, BY PRODUCT
8.1.1. DIAGNOSTIC ULTRASOUND DEVICES
8.1.1.1. MARKET REVENUE AND FORECAST
8.1.2. THERAPEUTIC ULTRASOUND DEVICES
8.1.2.1. MARKET REVENUE AND FORECAST
CHAPTER 9. GLOBAL ULTRASOUND MARKET, BY PORTABILITY
9.1. ULTRASOUND MARKET, BY PORTABILITY
9.1.1. CART/TROLLEY
9.1.1.1. MARKET REVENUE AND FORECAST
9.1.2. HANDHELD
9.1.2.1. MARKET REVENUE AND FORECAST
9.1.3. COMPACT
9.1.3.1. MARKET REVENUE AND FORECAST
CHAPTER 10. GLOBAL ULTRASOUND MARKET, BY APPLICATION
10.1. ULTRASOUND MARKET, BY APPLICATION
10.1.1. CARDIOLOGY
10.1.1.1. MARKET REVENUE AND FORECAST
10.1.2. OBSTETRICS/GYNAECOLOGY
10.1.2.1. MARKET REVENUE AND FORECAST
10.1.3. RADIOLOGY
10.1.3.1. MARKET REVENUE AND FORECAST
10.1.4. ORTHOPAEDIC
10.1.4.1. MARKET REVENUE AND FORECAST
10.1.5. ANESTHESIA
10.1.5.1. MARKET REVENUE AND FORECAST
10.1.6. EMERGENCY MEDICINE
10.1.6.1. MARKET REVENUE AND FORECAST
10.1.7. PRIMARY CARE
10.1.7.1. MARKET REVENUE AND FORECAST
10.1.8. CRITICAL CARE
10.1.8.1. MARKET REVENUE AND FORECAST
CHAPTER 11. GLOBAL ULTRASOUND MARKET, BY END-USE
11.1. ULTRASOUND MARKET, BY END-USE
11.1.1. HOSPITALS
11.1.1.1. MARKET REVENUE AND FORECAST
11.1.2. IMAGING CENTRES
11.1.2.1. MARKET REVENUE AND FORECAST
11.1.3. RESEARCH CENTRES
11.1.3.1. MARKET REVENUE AND FORECAST
CHAPTER 12. GLOBAL ULTRASOUND MARKET, REGIONAL ESTIMATES AND TREND FORECAST
12.1. NORTH AMERICA
12.1.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.1.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.1.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.1.4. MARKET REVENUE AND FORECAST, BY END-USE
12.1.5. U.S.
12.1.5.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.1.5.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.1.5.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.1.5.4. MARKET REVENUE AND FORECAST, BY END-USE
12.1.6. REST OF NORTH AMERICA
12.1.6.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.1.6.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.1.6.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.1.6.4. MARKET REVENUE AND FORECAST, BY END-USE
12.2. EUROPE
12.2.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.2.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.2.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.2.4. MARKET REVENUE AND FORECAST, BY END-USE
12.2.5. UK
12.2.5.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.2.5.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.2.5.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.2.5.4. MARKET REVENUE AND FORECAST, BY END-USE
12.2.6. GERMANY
12.2.6.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.2.6.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.2.6.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.2.6.4. MARKET REVENUE AND FORECAST, BY END-USE
12.2.7. FRANCE
12.2.7.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.2.7.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.2.7.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.2.7.4. MARKET REVENUE AND FORECAST, BY END-USE
12.2.8. REST OF EUROPE
12.2.8.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.2.8.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.2.8.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.2.8.4. MARKET REVENUE AND FORECAST, BY END-USE
12.3. APAC
12.3.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.3.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.3.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.3.4. MARKET REVENUE AND FORECAST, BY END-USE
12.3.5. INDIA
12.3.5.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.3.5.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.3.5.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.3.5.4. MARKET REVENUE AND FORECAST, BY END-USE
12.3.6. CHINA
12.3.6.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.3.6.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.3.6.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.3.6.4. MARKET REVENUE AND FORECAST, BY END-USE
12.3.7. JAPAN
12.3.7.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.3.7.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.3.7.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.3.7.4. MARKET REVENUE AND FORECAST, BY END-USE
12.3.8. REST OF APAC
12.3.8.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.3.8.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.3.8.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.3.8.4. MARKET REVENUE AND FORECAST, BY END-USE
12.4. MEA
12.4.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.4.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.4.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.4.4. MARKET REVENUE AND FORECAST, BY END-USE
12.4.5. GCC
12.4.5.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.4.5.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.4.5.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.4.5.4. MARKET REVENUE AND FORECAST, BY END-USE
12.4.6. NORTH AFRICA
12.4.6.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.4.6.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.4.6.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.4.6.4. MARKET REVENUE AND FORECAST, BY END-USE
12.4.7. SOUTH AFRICA
12.4.7.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.4.7.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.4.7.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.4.7.4. MARKET REVENUE AND FORECAST, BY END-USE
12.4.8. REST OF MEA
12.4.8.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.4.8.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.4.8.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.4.8.4. MARKET REVENUE AND FORECAST, BY END-USE
12.5. LATIN AMERICA
12.5.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.5.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.5.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.5.4. MARKET REVENUE AND FORECAST, BY END-USE
12.5.5. BRAZIL
12.5.5.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.5.5.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.5.5.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.5.5.4. MARKET REVENUE AND FORECAST, BY END-USE
12.5.6. REST OF LATAM
12.5.6.1. MARKET REVENUE AND FORECAST, BY PRODUCT
12.5.6.2. MARKET REVENUE AND FORECAST, BY PORTABILITY
12.5.6.3. MARKET REVENUE AND FORECAST, BY APPLICATION
12.5.6.4. MARKET REVENUE AND FORECAST, BY END-USE
CHAPTER 13. COMPANY PROFILES
13.1. ZIMMER MEDIZINSYSTEME GMBH
13.1.1. COMPANY OVERVIEW
13.1.2. PRODUCT OFFERINGS
13.1.3. FINANCIAL PERFORMANCE
13.1.4. RECENT INITIATIVES
13.2. GENERAL ELECTRIC HEALTHCARE
13.2.1. COMPANY OVERVIEW
13.2.2. PRODUCT OFFERINGS
13.2.3. FINANCIAL PERFORMANCE
13.2.4. RECENT INITIATIVES
13.3. FUJIFILM CORPORATION
13.3.1. COMPANY OVERVIEW
13.3.2. PRODUCT OFFERINGS
13.3.3. FINANCIAL PERFORMANCE
13.3.4. RECENT INITIATIVES
13.4. HITACHI, LTD.
13.4.1. COMPANY OVERVIEW
13.4.2. PRODUCT OFFERINGS
13.4.3. FINANCIAL PERFORMANCE
13.4.4. RECENT INITIATIVES
13.5. MINDRAY MEDICAL INTERNATIONAL LIMITED.
13.5.1. COMPANY OVERVIEW
13.5.2. PRODUCT OFFERINGS
13.5.3. FINANCIAL PERFORMANCE
13.5.4. RECENT INITIATIVES
13.6. SAMSUNG HEALTHCARE
13.6.1. COMPANY OVERVIEW
13.6.2. PRODUCT OFFERINGS
13.6.3. FINANCIAL PERFORMANCE
13.6.4. RECENT INITIATIVES
13.7. SIEMENS HEALTHINEERS AG
13.7.1. COMPANY OVERVIEW
13.7.2. PRODUCT OFFERINGS
13.7.3. FINANCIAL PERFORMANCE
13.7.4. RECENT INITIATIVES
13.8. KONINKLIJKE PHILIPS N.V.
13.8.1. COMPANY OVERVIEW
13.8.2. PRODUCT OFFERINGS
13.8.3. FINANCIAL PERFORMANCE
13.8.4. RECENT INITIATIVES
13.9. CANON INC.
13.9.1. COMPANY OVERVIEW
13.9.2. PRODUCT OFFERINGS
13.9.3. FINANCIAL PERFORMANCE
13.9.4. RECENT INITIATIVES
13.10. ESAOTE SPA
13.10.1. COMPANY OVERVIEW
13.10.2. PRODUCT OFFERINGS
13.10.3. FINANCIAL PERFORMANCE
13.10.4. RECENT INITIATIVES
CHAPTER 14. RESEARCH METHODOLOGY
14.1. PRIMARY RESEARCH
14.2. SECONDARY RESEARCH
14.3. ASSUMPTIONS
CHAPTER 15. APPENDIX
15.1. ABOUT US
15.2. GLOSSARY OF TERMS
著作権 ©2022 無断複写・転載を禁じます
